View in EDS

Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)

Saved in:
Bibliographic Details
Title: Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)
Authors: Atthobari J (AUTHOR), Asselbergs FW (AUTHOR), Boersma C (AUTHOR), de Vries R (AUTHOR), Hillege HL (AUTHOR), van Gilst WH (AUTHOR), Gansevoort RT (AUTHOR), de Jong PE (AUTHOR), de Jong-van den Berg LT (AUTHOR), Postma MJ (AUTHOR), PREVEND IT Study Group (CORPORATE AUTHOR)
Source: Clinical Therapeutics. Mar2006, Vol. 28 Issue 3, p432-444. 13p.
Database: Academic Search Ultimate
FullText Text:
  Availability: 0
Header DbId: asn
DbLabel: Academic Search Ultimate
An: 105868683
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AR" term="%22Atthobari+J%22">Atthobari J</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Asselbergs+FW%22">Asselbergs FW</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Boersma+C%22">Boersma C</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Vries+R%22">de Vries R</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Hillege+HL%22">Hillege HL</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22van+Gilst+WH%22">van Gilst WH</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Gansevoort+RT%22">Gansevoort RT</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Jong+PE%22">de Jong PE</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22de+Jong-van+den+Berg+LT%22">de Jong-van den Berg LT</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22Postma+MJ%22">Postma MJ</searchLink> (AUTHOR)<br /><searchLink fieldCode="AR" term="%22PREVEND+IT+Study+Group%22">PREVEND IT Study Group</searchLink> (CORPORATE AUTHOR)
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22Clinical+Therapeutics%22">Clinical Therapeutics</searchLink>. Mar2006, Vol. 28 Issue 3, p432-444. 13p.
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=asn&AN=105868683
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1016/j.clinthera.2006.03.012
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        PageCount: 13
        StartPage: 432
    Titles:
      – TitleFull: Cost-effectiveness of screening for albuminuria with subsequent fosinopril treatment to prevent cardiovascular events: A pharmacoeconomic analysis linked to the prevention of renal and vascular endstage disease (PREVEND) study and the prevention of renal and vascular endstage disease intervention trial (PREVEND IT)
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Atthobari J
      – PersonEntity:
          Name:
            NameFull: Asselbergs FW
      – PersonEntity:
          Name:
            NameFull: Boersma C
      – PersonEntity:
          Name:
            NameFull: de Vries R
      – PersonEntity:
          Name:
            NameFull: Hillege HL
      – PersonEntity:
          Name:
            NameFull: van Gilst WH
      – PersonEntity:
          Name:
            NameFull: Gansevoort RT
      – PersonEntity:
          Name:
            NameFull: de Jong PE
      – PersonEntity:
          Name:
            NameFull: de Jong-van den Berg LT
      – PersonEntity:
          Name:
            NameFull: Postma MJ
      – PersonEntity:
          Name:
            NameFull: PREVEND IT Study Group
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 03
              Text: Mar2006
              Type: published
              Y: 2006
          Identifiers:
            – Type: issn-print
              Value: 01492918
          Numbering:
            – Type: volume
              Value: 28
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Clinical Therapeutics
              Type: main
ResultId 1